Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Hair extensions can cause hair loss and scalp damage, and these problems might be more common than people realize.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

Hormones control reproduction and are crucial for body balance.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.